跳至主要内容
临床试验/IRCT20231108059993N1
IRCT20231108059993N1招募中Unknown

Evaluation of pharmacokinetic parameters and in vitro bioequivalence study of generic desloratadine 5 mg tablets manufactured by Poorsina Pharmaceutical Company with brand drug in a cross-over and double-blind study in healthy Iranian volunteers.

Poorsina Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
Male

入选标准

  • All volunteers should be non smoking.
  • All volunteers should have generally (kidney, liver, respiratory system and neuropsychology) health.
  • All volunteers should Informed consent.

排除标准

  • Having special diseases.
  • being smoker.
  • Using drugs with contractions with des loratadine.
  • Having liver and kidney diseases.

研究者

发起方
Poorsina Pharmaceutical Company

相似试验

Bioequivalence study of Iranian drugs with brand... | 临床试验